In ER negative breast cancer high tumor levels of S1PR4 and SphK1 are associated with poor patient prognosis [256, 267], and in HER2+ cells S1PR4/HER2+ signaling is associated with metastasis [267]. Here, S1PR4 is linked to neoplasm.